Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 701 to 725 of 2047

TitleReference numberPublishedLast updated
Rehabilitation after traumatic injuryNG211
Cabotegravir with rilpivirine for treating HIV-1TA757
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Endo-SPONGE for treating low rectal anastomotic leakHTG605
Transanal total mesorectal excision for rectal cancerHTG603
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseHTG604
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Colorectal cancerNG151
Prostate cancer: diagnosis and managementNG131
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsHTG602
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Dupilumab for treating severe asthma with type 2 inflammationTA751
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Synergo for non-muscle-invasive bladder cancerHTG601
Fever in under 5s: assessment and initial managementNG143
Givosiran for treating acute hepatic porphyriaHST16
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Coronary sinus narrowing device implantation for refractory anginaHTG600
Chronic kidney disease: assessment and managementNG203
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747

Results per page

  1. 10
  2. 25
  3. 50
  4. All